Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 4Thoracic 2Genitourinary 2Gastrointestinal 2Dermatologic 2Breast 2Head & Neck 1

Conditions

Breast Neoplasms 119Triple Negative Breast Neoplasms 8Inflammatory Breast Neoplasms 8Colorectal Neoplasms 8Ovarian Neoplasms 6Neoplasms 6Stomach Neoplasms 5Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 4Breast Neoplasms, Male 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Lung Neoplasms 3Head and Neck Neoplasms 3Esophageal Neoplasms 3Carcinoma, Renal Cell 3Multiple Myeloma 2Melanoma 2Hematologic Neoplasms 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2Colonic Neoplasms 2Women With Primary Breast Cancer 1Tracheal Neoplasms 1Thyroid Neoplasms 1Thrombocytosis 1Solitary Pulmonary Nodule 1

Interventions

pembrolizumab 8Carboplatin 6Cyclophosphamide 5veliparib 4olaparib 4Magnetic Resonance Spectroscopy 4liposomal doxorubicin 3Taxes 3Paclitaxel 3Gene Expression Profiling 3Gemcitabine 3palbociclib 2niraparib 2fludarabine 2durvalumab 2Temozolomide 2Specimen Handling 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Oxaliplatin 2Nivolumab 2Leucovorin 2Interleukin-2 2Fulvestrant 2Fluorouracil 2Early Intervention, Educational 2Drug Therapy 2Doxorubicin 2Biopsy 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Fluorouracil × Breast × Clear all
NCT02419495 2025-06-04

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

M.D. Anderson Cancer Center

Phase 1 Terminated
221 enrolled
BreastDermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Triple Negative Breast Neoplasms

NCT02658214 2020-08-20

Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid Tumors

AstraZeneca

Phase 1 Completed
32 enrolled
BreastGastrointestinalGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Carcinoma, Pancreatic Ductal, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡